Date of publication: January 16,
2006
Source:
http://gmoinfo.jrc.it/gmp_browse_geninf.asp
Notification number:
B/FR/06/01/09
Member State: France
Date of Acknowledgement: 12/12/2005
Title of the Project:
Application for the deliberate release of genetically
modified 1507x59122 (DAS-Ø15Ø7-1xDAS-59122-7) maize
Proposed period of release From:01/04/2006
To:31/12/2009
Name of the Institute(s) or Company(ies): Pioneer
Genetique;
3. Is the same GMPt release planned elsewhere in the
Community?
No
4 - Has the same GMPt been notified elsewhere by the same
notifier?
No
Genetically
modified plant
1. Complete name of the
recipient or parental plant(s)
|
Common Name
|
Family Name
|
Genus |
Species
|
Subspecies
|
Cultivar/breeding line
|
| maize
|
poaceae |
zea
|
zea
mays |
mays
|
experimental varieties |
2. Description of the traits and characteristics which have
been introduced or modified, including marker genes and previous
modifications:
The genetically modified 1507x59122 maize varieties that will
be tested in these field trials are resistant to certain
Lepidopteran insects, such as European corn borer (Ostrinia
nubilalis) and to certain Coleopteran insects, such as Western
corn rootworm (Diabrotica virgifera virgifera), and tolerant to
glufosinate-ammonium herbicide. This maize was derived through
traditional breeding methods between progeny of the genetically
modified 1507 maize and 59122 maize.
Genetic
modification
3. Type of genetic
modification:
Insertion;
4. In case of insertion of genetic material, give the source
and intended function of each constituent fragment of the region
to be inserted:
The genes introduced in 1507x59122 maize are the cry1F gene
from Bacillus thuringiensis var. aizawai, providing resistance
to certain Lepidopteran insects and the pat gene from
Streptomyces viridochromogenes, introduced as a selectable
marker, providing tolerance to glufosinate-ammonium herbicide,
like in 1507 maize, and the cry34Ab1 and cry35Ab1 genes from
Bacillus thuringiensis strain PS149B1, providing resistance to
certain Coleopteran insects and the pat gene from Streptomyces
viridochromogenes, introduced as a selectable marker, providing
tolerance to glufosinate herbicide, like 59122 maize, along with
their regulatory components necessary for expression in maize
plant:
- the cry1F gene, the UBIZM1(2) promoter, the ORF25PolyA
terminator.
- the pat gene, the CaMV35S promoter, the CaMV35S terminator.
- the cry34Ab1 gene, the UBIZM1(2) promoter, the PINII
terminator.
- the cry35Ab1 gene, the Peroxidase promoter, the PINII
terminator.
- the pat gene, the CaMV35S promoter, the CaMV35S terminator.
6. Brief description of the method used for the genetic
modification:
No genetic modification was made on the 1507x59122 maize
varieties directly: they were derived through traditional
breeding methods between progeny of the genetically modified
1507 and 59122 maize.
1507 maize was genetically modified using a particle
acceleration method. 59122 maize was genetically modified using
Agrobacterium transformation method.
7. If the recipient or parental plant is a forest tree
species, describe ways and extent of dissemination and specific
factors affecting dissemination:
Not applicable.
Experimental
Release
1. Purpose of the release:
The purpose of the release is to collect additional data on
1507x59122 maize. Studies will be carried out to observe the
plant behavior and the expression of the genes introduced.
2. Geographical location of the site:
The releases are planned at several locations in France
within the following areas:
Nord-Pas-de-Calais (Nord), Picardie (Aisne, Oise, Somme),
Bourgogne (Saône et Loire), Rhône-Alpes (Ain, Isère, Drome),
Centre (Eure et Loir, Loir et Cher, Indre, Indre et Loire,
Loiret), Aquitaine (Landes, Lot et Garonne), Midi-Pyrénées
(Haute-Garonne, Gers, Tarn, Tarn et Garonne),
Languedoc-Roussillon (Aude).
3. Size of the site (m2):
Every year there could have up to 12 sites of release, each
sown with up to 5000 m² of genetically modified 1507x59122 maize
subject of this notification. Other genetically modified maize
may be planted on the same sites of release. Thus, the total
trial surface for each site (all varieties and borders included)
will be larger.
4. Relevant data regarding previous releases carried out with
the same GM-plant, if any, specifically related to the potential
environmental and human health impacts from the release:
Many field trials have already been conducted at several
locations across maize growing regions in North America, South
America and Europe and no environmental problems were reported
for these trials. The transgenic plants were indistinguishable
from the non-genetically modified maize plants except for
showing resistance to certain Lepidopteran insects such as
European corn borer and certain Coleopteran insects, such as
Western corn rootworm, and showing tolerance when glufosinate
and glyphosate herbicides were applied, traits due to the
genetic modifications.
Environmental
Impact and Risk Management
Summary of the potential
environmental impact from the release of the GMPts:
No risks to human and animal health or the environment from
the deliberate release of genetically modified 1507x59122 maize,
resistant to Lepidopteran and certain Coleopteran insects and
tolerant to glufosinate herbicide, are expected, as per
information contained in the environmental risk assessment
included in the notification.
Brief description of any measures taken for the management of
risks:
The shedding of pollen from the genetically modified plants
will be controlled by maintaining a 200-meter isolation distance
with any other non-experimental maize crop. In addition, the
trial site will be surrounded by four border rows of
conventional maize of a similar relative maturity that will be
also destroyed at the end of the release.
Seed dispersal of individual kernels does not generally occur.
They are fixed on a cob and enclosed in many husks that protect
the seeds from outside contact. When a few seeds need to be
collected for analysis; this will be done by sampling the whole
ear and unused seeds will be destroyed.
In case of any emergency, the trial could be stopped by
application of a non-selective herbicide, other than
glufosinate, or by mechanical destruction and incorporation into
the soil.
At the end of the release, all remaining plant matter that has
not been harvested for analyses will be destroyed by chopping
and incorporating into the soil. No plant or plant product
coming from the trials will enter the food or feed chains.
Volunteer maize will be monitored during the following year in
order to ensure their destruction, if needed.
No commercial maize will be cultivated in the trial site the
following year.
Summary of foreseen field trial studies focused to gain new
data on environmental and human health impact from the release:
Not applicable to this release.
Final report
-
European
Commission administrative information
Consent given by the Competent
Authority: Not Known |
